Vistusertib API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Vistusertib is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Vistusertib or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Vistusertib API 1009298-59-2?

Description:
Here you will find a list of producers, manufacturers and distributors of Vistusertib. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Vistusertib 
Synonyms:
 
Cas Number:
1009298-59-2 
DrugBank number:
DB11925 
Unique Ingredient Identifier:
0BSC3P4H5X

General Description:

Vistusertib, identified by CAS number 1009298-59-2, is a notable compound with significant therapeutic applications. Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.

Classification:

Vistusertib belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond, classified under the direct parent group Phenylpyridines. This compound is a part of the Organic compounds, falling under the Organoheterocyclic compounds superclass, and categorized within the Pyridines and derivatives class, specifically within the Phenylpyridines subclass.

Categories:

Vistusertib is categorized under the following therapeutic classes: Acids, Carbocyclic, Amides, Benzene Derivatives, Benzoates, Oxazines, Protein Kinase Inhibitors. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.